These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 17709884)

  • 1. Novel inhibitors of glycation and AGE formation.
    Rahbar S
    Cell Biochem Biophys; 2007; 48(2-3):147-57. PubMed ID: 17709884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of early renal disease, dyslipidaemia and lipid peroxidation in STZ-diabetic rats by LR-9 and LR-74, novel AGE inhibitors.
    Figarola JL; Scott S; Loera S; Xi B; Synold T; Weiss L; Rahbar S
    Diabetes Metab Res Rev; 2005; 21(6):533-44. PubMed ID: 15818713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats.
    Figarola JL; Scott S; Loera S; Tessler C; Chu P; Weiss L; Hardy J; Rahbar S
    Diabetologia; 2003 Aug; 46(8):1140-52. PubMed ID: 12845431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renoprotective and lipid-lowering effects of LR compounds, novel advanced glycation end product inhibitors, in streptozotocin-induced diabetic rats.
    Figarola JL; Scott S; Loera S; Xi B; Synold T; Rahbar S
    Ann N Y Acad Sci; 2005 Jun; 1043():767-76. PubMed ID: 16037304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a new advanced glycation inhibitor, LR-90, on mitigating arterial stiffening and improving arterial elasticity and compliance in a diabetic rat model: aortic impedance analysis.
    Satheesan S; Figarola JL; Dabbs T; Rahbar S; Ermel R
    Br J Pharmacol; 2014 Jun; 171(12):3103-14. PubMed ID: 24611770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
    Ojima A; Ishibashi Y; Matsui T; Maeda S; Nishino Y; Takeuchi M; Fukami K; Yamagishi S
    Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
    Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
    Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.
    Degenhardt TP; Alderson NL; Arrington DD; Beattie RJ; Basgen JM; Steffes MW; Thorpe SR; Baynes JW
    Kidney Int; 2002 Mar; 61(3):939-50. PubMed ID: 11849448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats.
    Bhatwadekar A; Glenn JV; Figarola JL; Scott S; Gardiner TA; Rahbar S; Stitt AW
    Br J Ophthalmol; 2008 Apr; 92(4):545-7. PubMed ID: 18211931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN).
    Yuan Y; Sun H; Sun Z
    Lipids Health Dis; 2017 Jun; 16(1):126. PubMed ID: 28659153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription.
    Liu IM; Tzeng TF; Liou SS; Chang CJ
    J Ethnopharmacol; 2009 Jul; 124(2):211-8. PubMed ID: 19397971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XLF-III-43, a novel coumarin-aspirin compound, prevents diabetic nephropathy in rats via inhibiting advanced glycation end products.
    Li H; Zheng X; Wang H; Zhang Y; Xin H; Chen X
    Eur J Pharmacol; 2010 Feb; 627(1-3):340-7. PubMed ID: 19895808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAGE-Aptamer Blocks the Development and Progression of Experimental Diabetic Nephropathy.
    Matsui T; Higashimoto Y; Nishino Y; Nakamura N; Fukami K; Yamagishi SI
    Diabetes; 2017 Jun; 66(6):1683-1695. PubMed ID: 28385802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syzygium cumini (L.) skeels mitigate diabetic nephropathy by regulating Nrf2 pathway and mitocyhondrial dysfunction: In vitro and in vivo studies.
    Bangar NS; Dixit A; Apte MM; Tupe RS
    J Ethnopharmacol; 2025 Jan; 336():118684. PubMed ID: 39127117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Swertiamarin mitigates nephropathy in high-fat diet/streptozotocin-induced diabetic rats by inhibiting the formation of advanced glycation end products.
    Parwani K; Patel F; Bhagwat P; Dilip H; Patel D; Thiruvenkatam V; Mandal P
    Arch Physiol Biochem; 2024 Apr; 130(2):136-154. PubMed ID: 34657540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of glyoxalase 1 by mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats.
    Liu YW; Zhu X; Zhang L; Lu Q; Wang JY; Zhang F; Guo H; Yin JL; Yin XX
    Eur J Pharmacol; 2013 Dec; 721(1-3):355-64. PubMed ID: 24036348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications.
    Metz TO; Alderson NL; Thorpe SR; Baynes JW
    Arch Biochem Biophys; 2003 Nov; 419(1):41-9. PubMed ID: 14568007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes.
    Forbes JM; Thallas V; Thomas MC; Founds HW; Burns WC; Jerums G; Cooper ME
    FASEB J; 2003 Sep; 17(12):1762-4. PubMed ID: 12958202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteomeles schwerinae extracts inhibits the binding to receptors of advanced glycation end products and TGF-β1 expression in mesangial cells under diabetic conditions.
    Kim YS; Jung DH; Lee IS; Pyun BJ; Kim JS
    Phytomedicine; 2016 Apr; 23(4):388-97. PubMed ID: 27002409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotective effect of atorvastatin on STZ-diabetic rats through attenuating kidney-associated dysmetabolism.
    Zhou S; Zhao P; Li Y; Deng T; Tian L; Li H
    Eur J Pharmacol; 2014 Oct; 740():9-14. PubMed ID: 25008071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.